July 21, 2004 Biotech firm Avesthagen has signed an agreement with the Raisio Group of Finland's Raisio Group to market the global corporations's top-selling product, Benecol in India. Benecol is a plant-derived product, which in 40 separate clinical trails conducted globally, has been shown to lower cholesterol levels. Benecol will be marketed by AQUAS, the services and sales arm of Avesthagen. "Avesthagen is rolling out its functional food programme with the marketing of Benecol". AQUAS senior vice president, Tehmaas Gorimaar said. |